1. This venture represents the culmination point of over 10 years of participation as a NORD Corporate Council member

2. 2 Our Work  Goal: minimize gap of over 100 approved orphan therapies between US & Canada

3. Vision To improve the health and quality of life of Canadians with rare diseases Mission To bring currently unavailable orphan drugs for women, men and children with rare diseases in Canada. Through in-licensing partnerships, we offer turn-key operations, including the approval process and commercialization of novel treatments www.MedunikCanada.com

4. 4 Medunik Canada Advisory Board

5. 5 Infrastructure Suited to Specialty Products  Montreal Headquarters (57,000 sq ft) - Distribution Center - Manufacturing - FDA Approved Site, 2011 - Management & Administration - Market Access - Marketing - PMPRB - Regulatory Affairs - Medical Information Services  Employee Base (54 FTEs)

6. 6 Medunik Canada Why work with Medunik Canada for the Canadian Market?  Family owned business  Funding available, willing to take the financial risk  Well established expertise and knowledge of canadian regulations  Strong will to make a difference for Canadians